Agreed, great analysis. I think there's a good chance BSX will get back to $40/share in the next month, once their earnings report will continue to show their double digit growth. With all of JNJ's problems, I think FDA will shut JNJ down, and we all know MDT and STJ are dead companies with crappy, obsolete products. Only BSX has solid, innovative, game-changing bulletproof products, and the most talented employees in the world. BSX invented the stent, invented the pacemaker, and invented the ICD. GO BSX!!